Sectoral Asset Management Inc Allovir, Inc. Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$6.75 - $13.52 $1.76 Million - $3.53 Million	-261,051 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$12.94 - $25.99 $30,072 - $60,400	-2,324 Reduced 0.88%	261,051 $3.38 Million
Q3 2021 Nov 15, 2021	BUY	$16.97 - $25.06 $3.88 Million - $5.72 Million	228,425 Added 653.58%	263,375 $6.6 Million
Q2 2021 Aug 16, 2021	BUY	$19.44 - $25.06 $262,440 - $338,310	13,500 Added 62.94%	34,950 $690,000
Q1 2021 May 14, 2021	BUY	$20.81 - $45.5 $243,560 - $532,532	11,704 Added 120.09%	21,450 $502,000
Q4 2020 Feb 12, 2021	SELL	$23.94 - $46.81 $6.42 Million - $12.5 Million	-268,049 Reduced 96.49%	9,746 $375,000
Q3 2020 Nov 13, 2020	BUY	$21.05 - $42.7 $5.85 Million - $11.9 Million	277,795 New	277,795 $7.64 Million

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $37.2M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.